ARCA biopharma, Inc.

NASDAQ:ABIO

28.8 (USD) • At close August 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Operating Activities:
Net Income -5.339-9.926-19.322-9.738-5.482-7.933-18.49-16.444-11.445-9.689-6.939-4.32-5.364-8.42-9.138-29.923-12.301-130.553-71.611-52.489-50.187-44.978-36.472-22.253-18.5-16.4-6.5-4.8
Depreciation & Amortization 0.1110.1140.0910.0930.0890.0220.3560.320.0190.0120.0260.0430.6020.3380.4572.2852.3433.1822.6684.1175.5296.2625.1043.124321.20.4
Deferred Income Tax -0.9080-1.090.872-0.14100.017-0.01900003.380-2.2814.663013.5691.2341.5290.66-0.015000000
Stock Based Compensation 0.6860.5560.4970.0430.1510.2730.4580.5760.5990.6470.2830.3060.3080.4580.8454.609011.2570.5610.2790.490.015000000
Change In Working Capital -0.472-1.661-0.0281.8770.441-0.6080.0850.40.104-0.4431.342-0.107-0.521-0.433-13.13-28.273-48.55453.7748.144-1.216-3.7622.52732.9639.3612.62.6-2.80.1
Accounts Receivables 0000000000000000038.4370.1990.070.532-0.579000000
Inventory 0000000000000000012.448-1.624-8.611-28.92844.809000000
Accounts Payables 0.028-0.783-0.4111.1010.188-0.392-0.5830.841-0.4310.1980.532-0.195-0.128-0.145-2.46-1.04502.1071.8120.997-1.136-0.975000000
Other Working Capital -0.5-0.8780.3830.7760.253-0.2160.668-0.4410.535-0.6410.810.088-0.393-0.288-10.67-27.228-48.5540.7827.7576.32825.772-20.72832.9639.3612.62.6-2.80.1
Other Non Cash Items 0.9080.0051.09-0.8720.1410.0020.1020.180.1890.0670.0010-5.364-0.267-18.4790.13112.55411.711-0.031-2.3322.202-15.13-23.133-11.219-0.10.1-0.10
Operating Cash Flow -5.014-10.912-18.762-7.725-4.801-8.244-17.472-14.987-10.534-9.406-5.288-4.078-6.959-8.324-41.726-46.508-45.958-37.06-59.035-50.112-45.066-31.319-21.538-20.987-13-11.7-8.1-4.3
Investing Activities:
Investments In Property Plant And Equipment 0-0.002-0.043-0.019-0.004-0.004-0.003-0.012-0.011-0.019-0.0320-0.019-0.004-0.185-0.222-0.381-2.442-2.57-0.664-0.32-2.063-12.582-8.269-4.4-4.6-3.1-0.9
Acquisitions Net 0000000000000030.39200.1360000.7450000000
Purchases Of Investments 000000-5.471-20.5040000000-44.609-116.606-114.586-62.766-63.823-20.22700-57.101-16.4-44.5-38.90
Sales Maturities Of Investments 000003.0518.44.102000000.26315.10694.996143.93654.42464.16150.86622.480074.09524.353.650
Other Investing Activites 000000.0030.013-0.01600002.0250.0060.3220.018-60.5400.04525.7150.473-0.5420.00900-0.10
Investing Cash Flow 0-0.002-0.043-0.019-0.0043.04612.926-16.414-0.011-0.019-0.03202.0060.26545.63550.18321.085-62.064-1.175-13.57628.393-1.59-13.1248.7343.54.5-37.1-0.9
Financing Activities:
Debt Repayment 00000000000000-412.75-3.827-8.342-3.375-4.741-1.7767.50921.633-0.211.55.10.10.7
Common Stock Issued 0024.0750.8947.2813.5326.5510379.0381.7411.5284.7267.6590.1140.0540.426130.03784.34771.78928.0114.79622.1591.4870.20.561.510.2
Common Stock Repurchased 000000000000000000000000-0.1000
Dividends Paid 0000000000000000000000000000
Other Financing Activities 00-0.977-2.442-0.721-0.428-0.7040-3.007-1.01517.415-0.473-0.855-0.33800000.1910.311.3550.50.500000.3
Financing Cash Flow 0023.09348.4526.563.1045.847033.9938.02319.1561.0553.8717.321-3.8860.155-3.401121.69581.16367.35827.58922.80544.2921.2771.65.661.611.2
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000000000
Net Change In Cash -5.014-10.9144.28840.7081.755-2.0941.301-31.40123.448-1.40213.836-3.023-1.082-0.7380.0233.83-28.27422.57120.9533.6710.916-10.1049.63-10.976-7.9-1.616.46
Cash At End Of Period 37.43142.44553.35949.0718.3636.6088.7027.40138.80215.35416.7562.925.9437.0257.76335.89132.06160.33537.76416.81113.1412.22512.3292.69913.721.623.16.8